デフォルト表紙
市場調査レポート
商品コード
1769922

冠動脈ステントの世界市場:産業分析、市場規模・シェア・成長・動向・予測 (2025年~2035年)

Coronary Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035


出版日
ページ情報
英文 162 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
冠動脈ステントの世界市場:産業分析、市場規模・シェア・成長・動向・予測 (2025年~2035年)
出版日: 2025年05月09日
発行: Transparency Market Research
ページ情報: 英文 162 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

冠動脈ステント市場 - 分析範囲

TMRの調査レポート「世界の冠動脈ステント市場」は、2025年から2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019年から2035年までの世界の冠動脈ステント市場の収益と予測を提供します。また、2025年から2035年までの世界の冠動脈ステント市場の複合年間成長率(CAGR、%)も掲載しています。

当レポートは広範な調査を経て作成されています。一次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、冠動脈ステント市場を推察しました。

市場概況
市場規模(2024年) 72億2,250万米ドル
市場規模(2035年) 128億4,660万米ドル
CAGR 5.3%

当レポートでは、世界の冠動脈ステント市場の競合情勢について分析しています。世界の冠動脈ステント市場で事業を展開する主要企業が特定され、各企業がさまざまな属性でプロファイルされています。企業概要・財務状況・最新動向・SWOTが、当レポートで紹介されている世界の冠動脈ステント市場における各企業の属性です。

目次

第1章 序論

第2章 前提条件と分析手法

第3章 エグゼクティブサマリー:世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の冠動脈ステント市場分析と予測(2020~2035年)

第5章 主要洞察

  • 冠動脈ステントの概要
  • 技術的進歩
  • ポーターのファイブフォース分析
  • PESTEL分析
  • サプライチェーン分析
  • 主要な業界イベント
  • ブランドと価格分析
  • 主要地域/国における規制状況

第6章 世界市場の分析と予測:種類別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測(金額ベース):種類別(2020~2035年)
    • ベアメタルステント(BMS)
    • 薬剤溶出ステント(DES)
    • 生体吸収性血管スキャフォールド(BVS)
  • 市場の魅力:種類別

第7章 世界市場の分析と予測:材料別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測(金額ベース):材料別(2020~2035年)
    • 金属
    • ポリマー
  • 市場の魅力:材料別

第8章 世界市場の分析と予測:エンドユーザー別

  • イントロダクション・定義
  • 主な分析結果/進展
  • 市場予測(金額ベース):エンドユーザー別(2020~2035年)
    • 病院
    • 心臓センター
    • 外来手術センター
    • その他
  • 市場の魅力:エンドユーザー別

第9章 世界市場の分析と予測:地域別

  • 主な分析結果
  • 市場予測(金額ベース):地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力:地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東・アフリカ市場の分析と予測

第15章 競合情勢

  • 市場企業・競合マトリックス(企業の階層別・規模別)
  • 市場シェア分析:企業別(2024年)
  • 企業プロファイル
    • Abbott Laboratories
    • AlviMedica
    • B. Braun Melsungen AG
    • Biosensors International Group, Ltd.
    • Shandong JW Medical Systems LTD.
    • Boston Scientific Corporation
    • Cook Medical Inc.
    • Elixir Medical Corp.
    • Lepu Medical Technology(Beijing)Co., Ltd.
    • Medtronic plc
    • Eurocor GmbH
    • OrbusNeich Medical Company Limited
    • Shanghai MicroPort Medical Co., Ltd.
    • Sino Medical Sciences Technology Inc.
    • Terumo Corporation
    • Meril Life Sciences Pvt. Ltd.
    • Balton
図表

List of Tables

  • Table 01: Global Coronary Stents Market Value (US$ Mn) Forecast, By Type, 2020 to 2035
  • Table 02: Global Coronary Stents Market Value (US$ Mn) Forecast, By Material, 2020 to 2035
  • Table 03: Global Coronary Stents Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 04: Global Coronary Stents Market Value (US$ Mn) Forecast, By Region, 2020 to 2035
  • Table 05: North America - Coronary Stents Market Value (US$ Mn) Forecast, by Country, 2020 to 2035
  • Table 06: North America - Coronary Stents Market Value (US$ Mn) Forecast, By Type, 2020 to 2035
  • Table 07: North America - Coronary Stents Market Value (US$ Mn) Forecast, By Material, 2020 to 2035
  • Table 08: North America - Coronary Stents Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 09: Europe - Coronary Stents Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 10: Europe - Coronary Stents Market Value (US$ Mn) Forecast, By Type, 2020 to 2035
  • Table 11: Europe - Coronary Stents Market Value (US$ Mn) Forecast, By Material, 2020 to 2035
  • Table 12: Europe - Coronary Stents Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 13: Asia Pacific - Coronary Stents Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 14: Asia Pacific - Coronary Stents Market Value (US$ Mn) Forecast, By Type, 2020 to 2035
  • Table 15: Asia Pacific - Coronary Stents Market Value (US$ Mn) Forecast, By Material, 2020 to 2035
  • Table 16: Asia Pacific - Coronary Stents Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 17: Latin America - Coronary Stents Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 18: Latin America - Coronary Stents Market Value (US$ Mn) Forecast, By Type, 2020 to 2035
  • Table 19: Latin America - Coronary Stents Market Value (US$ Mn) Forecast, By Material, 2020 to 2035
  • Table 20: Latin America - Coronary Stents Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035
  • Table 21: Middle East & Africa - Coronary Stents Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 22: Middle East & Africa - Coronary Stents Market Value (US$ Mn) Forecast, By Type, 2020 to 2035
  • Table 23: Middle East & Africa - Coronary Stents Market Value (US$ Mn) Forecast, By Material, 2020 to 2035
  • Table 24: Middle East & Africa - Coronary Stents Market Value (US$ Mn) Forecast, By End-user, 2020 to 2035

List of Figures

  • Figure 01: Global Coronary Stents Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 02: Global Coronary Stents Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 03: Global Coronary Stents Market Revenue (US$ Mn), by Bare Metal Stent (BMS), 2020 to 2035
  • Figure 04: Global Coronary Stents Market Revenue (US$ Mn), by Drug Eluting Stent (DES), 2020 to 2035
  • Figure 05: Global Coronary Stents Market Revenue (US$ Mn), by Bioabsorbable Vascular Scaffold (BVS), 2020 to 2035
  • Figure 06: Global Coronary Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 07: Global Coronary Stents Market Attractiveness Analysis, By Material, 2025 to 2035
  • Figure 08: Global Coronary Stents Market Revenue (US$ Mn), by Metal, 2020 to 2035
  • Figure 09: Global Coronary Stents Market Revenue (US$ Mn), by Polymer, 2020 to 2035
  • Figure 10: Global Coronary Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 11: Global Coronary Stents Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 12: Global Coronary Stents Market Revenue (US$ Mn), by Hospitals, 2020 to 2035
  • Figure 13: Global Coronary Stents Market Revenue (US$ Mn), by Cardiac Centers, 2020 to 2035
  • Figure 14: Global Coronary Stents Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2020 to 2035
  • Figure 15: Global Coronary Stents Market Revenue (US$ Mn), by Others, 2020 to 2035
  • Figure 16: Global Coronary Stents Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 17: Global Coronary Stents Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 18: North America - Coronary Stents Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 19: North America - Coronary Stents Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 20: North America - Coronary Stents Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 21: North America - Coronary Stents Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 22: North America - Coronary Stents Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 23: North America - Coronary Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 24: North America - Coronary Stents Market Attractiveness Analysis, By Material, 2025 to 2035
  • Figure 25: North America - Coronary Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 26: North America - Coronary Stents Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 27: Europe - Coronary Stents Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 28: Europe - Coronary Stents Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 29: Europe - Coronary Stents Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 30: Europe - Coronary Stents Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 31: Europe - Coronary Stents Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 32: Europe - Coronary Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 33: Europe - Coronary Stents Market Attractiveness Analysis, By Material, 2025 to 2035
  • Figure 34: Europe - Coronary Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 35: Europe - Coronary Stents Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 36: Asia Pacific - Coronary Stents Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 37: Asia Pacific - Coronary Stents Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 38: Asia Pacific - Coronary Stents Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 39: Asia Pacific - Coronary Stents Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 40: Asia Pacific - Coronary Stents Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 41: Asia Pacific - Coronary Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 42: Asia Pacific - Coronary Stents Market Attractiveness Analysis, By Material, 2025 to 2035
  • Figure 43: Asia Pacific - Coronary Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 44: Asia Pacific - Coronary Stents Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 45: Latin America - Coronary Stents Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 46: Latin America - Coronary Stents Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 47: Latin America - Coronary Stents Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 48: Latin America - Coronary Stents Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 49: Latin America - Coronary Stents Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 50: Latin America - Coronary Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 51: Latin America - Coronary Stents Market Attractiveness Analysis, By Material, 2025 to 2035
  • Figure 52: Latin America - Coronary Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 53: Latin America - Coronary Stents Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 54: Middle East & Africa - Coronary Stents Market Value (US$ Mn) Forecast, 2020 to 2035
  • Figure 55: Middle East & Africa - Coronary Stents Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 56: Middle East & Africa - Coronary Stents Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 57: Middle East & Africa - Coronary Stents Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 58: Middle East & Africa - Coronary Stents Market Attractiveness Analysis, By Type, 2025 to 2035
  • Figure 59: Middle East & Africa - Coronary Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 60: Middle East & Africa - Coronary Stents Market Attractiveness Analysis, By Material, 2025 to 2035
  • Figure 61: Middle East & Africa - Coronary Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 62: Middle East & Africa - Coronary Stents Market Attractiveness Analysis, By End-user, 2025 to 2035
目次
Product Code: TMRGL23

Coronary Stents Market - Scope of Report

TMR's report on the global coronary stents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global coronary stents market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global coronary stents market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the coronary stents market.

Market Snapshot
Market Value in 2024US$ 7222.5 Mn
Market Value in 2035US$ 12846.6 Mn
CAGR5.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global coronary stents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global coronary stents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global coronary stents market.

The report delves into the competitive landscape of the global coronary stents market. Key players operating in the global coronary stents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global coronary stents market profiled in this report.

Key Questions Answered in Global coronary stents Market Report:

  • What is the sales/revenue generated by coronary stents across all regions during the forecast period?
  • What are the opportunities in the global coronary stents market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Coronary Stents Market - Research Objectives and Research Approach

The comprehensive report on the global coronary stents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global coronary stents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global coronary stents market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Coronary Stents Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Coronary Stents Market Analysis and Forecast, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Overview Of Coronary Stent
  • 5.2. Technological Advancements
  • 5.3. PORTER's Five Forces Analysis
  • 5.4. PESTLE Analysis
  • 5.5. Supply Chain Analysis
  • 5.6. Key Industry Events
  • 5.7. Brand and Pricing Analysis
  • 5.8. Regulatory Landscape across Key Regions / Countries

6. Global Coronary Stents Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2020 to 2035
    • 6.3.1. Bare Metal Stent (BMS)
    • 6.3.2. Drug Eluting Stent (DES)
    • 6.3.3. Bioabsorbable Vascular Scaffold (BVS)
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Coronary Stents Market Analysis and Forecast, by Material

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Material, 2020 to 2035
    • 7.3.1. Metal
    • 7.3.2. Polymer
  • 7.4. Market Attractiveness Analysis, by Material

8. Global Coronary Stents Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020 to 2035
    • 8.3.1. Hospitals
    • 8.3.2. Cardiac Centers
    • 8.3.3. Ambulatory Surgical Centers
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Coronary Stents Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020 to 2035
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Coronary Stents Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type, 2020 to 2035
    • 10.2.1. Bare Metal Stent (BMS)
    • 10.2.2. Drug Eluting Stent (DES)
    • 10.2.3. Bioabsorbable Vascular Scaffold (BVS)
  • 10.3. Market Value Forecast, by Material, 2020 to 2035
    • 10.3.1. Metal
    • 10.3.2. Polymer
  • 10.4. Market Value Forecast, by End-user, 2020 to 2035
    • 10.4.1. Hospitals
    • 10.4.2. Cardiac Centers
    • 10.4.3. Ambulatory Surgical Centers
    • 10.4.4. Others
  • 10.5. Market Value Forecast, by Country, 2020 to 2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Material
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Coronary Stents Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2020 to 2035
    • 11.2.1. Bare Metal Stent (BMS)
    • 11.2.2. Drug Eluting Stent (DES)
    • 11.2.3. Bioabsorbable Vascular Scaffold (BVS)
  • 11.3. Market Value Forecast, by Material, 2020 to 2035
    • 11.3.1. Metal
    • 11.3.2. Polymer
  • 11.4. Market Value Forecast, by End-user, 2020 to 2035
    • 11.4.1. Hospitals
    • 11.4.2. Cardiac Centers
    • 11.4.3. Ambulatory Surgical Centers
    • 11.4.4. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 11.5.1. Germany
    • 11.5.2. UK
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Material
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Coronary Stents Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2020 to 2035
    • 12.2.1. Bare Metal Stent (BMS)
    • 12.2.2. Drug Eluting Stent (DES)
    • 12.2.3. Bioabsorbable Vascular Scaffold (BVS)
  • 12.3. Market Value Forecast, by Material, 2020 to 2035
    • 12.3.1. Metal
    • 12.3.2. Polymer
  • 12.4. Market Value Forecast, by End-user, 2020 to 2035
    • 12.4.1. Hospitals
    • 12.4.2. Cardiac Centers
    • 12.4.3. Ambulatory Surgical Centers
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Material
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Coronary Stents Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2020 to 2035
    • 13.2.1. Bare Metal Stent (BMS)
    • 13.2.2. Drug Eluting Stent (DES)
    • 13.2.3. Bioabsorbable Vascular Scaffold (BVS)
  • 13.3. Market Value Forecast, by Material, 2020 to 2035
    • 13.3.1. Metal
    • 13.3.2. Polymer
  • 13.4. Market Value Forecast, by End-user, 2020 to 2035
    • 13.4.1. Hospitals
    • 13.4.2. Cardiac Centers
    • 13.4.3. Ambulatory Surgical Centers
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Material
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Coronary Stents Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2020 to 2035
    • 14.2.1. Bare Metal Stent (BMS)
    • 14.2.2. Drug Eluting Stent (DES)
    • 14.2.3. Bioabsorbable Vascular Scaffold (BVS)
  • 14.3. Market Value Forecast, by Material, 2020 to 2035
    • 14.3.1. Metal
    • 14.3.2. Polymer
  • 14.4. Market Value Forecast, by End-user, 2020 to 2035
    • 14.4.1. Hospitals
    • 14.4.2. Cardiac Centers
    • 14.4.3. Ambulatory Surgical Centers
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Material
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Abbott Laboratories
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. AlviMedica
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. B. Braun Melsungen AG
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Biosensors International Group, Ltd.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Shandong JW Medical Systems LTD.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Boston Scientific Corporation
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Cook Medical Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Elixir Medical Corp.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Lepu Medical Technology (Beijing) Co., Ltd.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Medtronic plc
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Eurocor GmbH
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. OrbusNeich Medical Company Limited
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Shanghai MicroPort Medical Co., Ltd.
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Sino Medical Sciences Technology Inc.
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Product Portfolio
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments
    • 15.3.15. Terumo Corporation
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Financial Overview
      • 15.3.15.3. Product Portfolio
      • 15.3.15.4. Business Strategies
      • 15.3.15.5. Recent Developments
    • 15.3.16. Meril Life Sciences Pvt. Ltd.
      • 15.3.16.1. Company Overview
      • 15.3.16.2. Financial Overview
      • 15.3.16.3. Product Portfolio
      • 15.3.16.4. Business Strategies
      • 15.3.16.5. Recent Developments
    • 15.3.17. Balton
      • 15.3.17.1. Company Overview
      • 15.3.17.2. Financial Overview
      • 15.3.17.3. Product Portfolio
      • 15.3.17.4. Business Strategies
      • 15.3.17.5. Recent Developments